LONDON, April 29, 2026 (BSS/AFP) - British pharmaceutical giant GSK on Wednesday reported a rise in first quarter net profit driven by strong demand for specialty medicines targeting cancer, HIV and respiratory diseases.

Profit after tax rose around seven percent from the same period last year to o1.7 billion ($2.3 billion), GSK said in a results statement.